UK 5 Year antimicrobial resistance plan
The UK's plan outlines their contribution to containing and controlling antimicrobial resistance (AMR) in health, animals, the environment and the food chain. The UK government...
Cancer Research UK tackles global cancer challenges with new funding
Cancer Research UK is funding three major new international research initiatives on the microbiome, chronic inflammation and why some cancers are specific to certain...
NICE recommends digital CBT for children with mild depression
NICE has recommended digital CBT for children and young people with mild depression as a first-line treatment. Digital cognitive behavioural therapy is delivered on mobile phones,...
The launch of GP Connect kicks off in Leeds
NHS Digital has taken a major step on the road to ensuring clinicians have access to patients’ GP records right across Leeds with the...
Asthma UK: There are more than 10 million asthma attacks each year
Every three seconds someone in the UK could be having a potentially life-threatening asthma attack, according to new research from Asthma UK. The new analysis,...
NICE: Procedure could make more livers viable for transplant
A procedure assessed by NICE has been hailed as an “exciting development” in increasing the number of livers viable for transplant. A perfusion machine can...
Outdated mental health commissioning contracts are failing services
A new report reveals that outdated mental health commissioning contracts are failing UK mental health services. The report published by the Janssen Pharmaceutical Companies of...
New measles and rubella elimination strategy launched
Public Health England has published a new measles and rubella elimination strategy. It makes recommendations on the steps needed to maintain the UK’s elimination status...
New Biodose software system launch
Dosecare, the medication management company, has announced it has developed new software for Biodose customers. Dosecare, which is owned by Issa Group, a family-owned business...
Initial response to the Long Term Plan
Sector response to the Long Term Plan has now been published and it has been welcomed in the main, though cautiously by some. The NHS...
Latest articles
Novo Nordisk presents oral semaglitude data at ENDO
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners on the positive patient outcomes that come from working together
The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Detecting and managing atrial fibrillation
The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Popular articles
Detecting and managing atrial fibrillation
The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)
Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics and precision medicine
How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Novo Nordisk presents oral semaglitude data at ENDO
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Addressing the skills shortage in life sciences
How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...